Mr. Tischler joined Athyrium in 2014 and currently serves as an Associate.
Prior to joining Athyrium, Mr. Tischler was a Senior Analyst at Frankel Group, a strategy consulting firm serving clients in the healthcare sector. While at Frankel Group, Mr. Tischler worked on due diligence, commercial opportunity assessment, and launch planning for pharmaceutical companies and private investors. His experience spans a wide range of therapeutic areas, including oncology, cardiology, and neurology.
Mr. Tischler holds a B.S. in Economics from The Wharton School and a B.A. in Biology from the University of Pennsylvania.